It is generally well appreciated that Information Technology (IT) is the engine room of the global economy. By it meant that IT is not just a sector of the economy, it is the very infrastructure that supports and drives the global economy, enabling growth and innovation.
It is a common question among futurists what will be the next great driver of future wealth and prosperity? By all indicators, that driver is most likely to be biotechnology (biotech).
Biotechnology is the use of biological systems, living organisms, or parts of them (often at the molecular or cellular level) to develop or create products, processes, or technologies that improve human health, agriculture, industry and other fields.
Many observers believe that biotech promises the greatest revolution in human history. They believe that it will transform every aspect of human life: our medical care, our food, our health, our entertainment, our very bodies. In terms of economic impact, biotech is already making a massive contribution. In 2019, the size of the global bioeconomy was estimated at approx. $5trillion accounting for roughly 6% of global GDP. Based on current trends of 10–15% annual revenue growth, the global bioeconomy could exceed $20 trillion by 2030.
Now one doesn’t expect such a powerful technology to appear overnight out of thin air. Biotechnology unsurprisingly, has a long history of intellectual antecedents that preceded and eventually precipitated it current bloom. It started in the mid to late 19th century with the work of Austrian monk and biologist, Gregor Mendel. Mendel carried out research that established the mathematical laws of genetic inheritance, describing how traits are passed from parents to offspring, thus giving birth to the field of modern genetics. Much of this work took place within a 10-year stretch from 1856 to 1866.
Biotechnology relies on the understanding of Mendelian genetics to predict and control the outcomes of genetic modifications. But Mendelian genetics was not enough. Further breakthroughs were needed to bring mankind on the brink of the biotech age.
The next major milestone would come very shortly after the culmination of Mendel’s work with discovery of DNA, the building blocks of life in 1868 by Fritz Miescher, a Swiss physician. While this was no doubt, a major milestone, by itself it wasn’t complete.
To be able to be in a position to launch the biotech age, it wasn’t just enough to understand DNA’s function. It was also important to decipher its structure. That didn’t happen until 1953. In the city of Cambridge, England, two young scientists: American James Watson and Briton Francis Crick managed to determine the exact structure of DNA using a technique known as x-ray crystallography. What they found is the now famous “double helix” shown below:

The deciphering of the structure of DNA gave birth to the field of molecular biology, which is the fundamental knowledge base that drives biotech research, but still further breakthroughs were needed. It was not until the 1970s that it could officially be said that the biotech age had finally arrived.
The biotech industry was actually jumpstarted in the 1970s with the invention of what is known as recombinant DNA technology by two biochemists named Herbert Boyer and Stanley Cohen. They would eventually form a company called Genentech, which is widely regarded as the mother company of the biotech industry.
Why recombinant DNA was such a big deal was because it enabled the DNA of two different organisms to be joined together (the technique for doing that is called splicing). DNA splicing made it possible to carry out genetic engineering, which gives one the ability to alter matter at the cellular level to suit one’s needs. Genetic engineering is at the heart of the biotech industry’s thrust to remake life as we know it.
In terms of application, biotech has roughly three broad uses and these are namely:
- Agricultural Biotechnology (Agbio)
- Medical Biotechnology
- Industrial Biotechnology
Agricultural biotechnology mainly consists of the genetic engineering of plants and animals in order to create better, more efficient plant/animal products marked for human consumption. It is important to note that the deliberate attempt to alter plant/animal species in order to create improved varieties has been a part and parcel of farming for more than 7,000 years. Genetic engineering and biotech just bring a level of precision to this important farming activity that was impossible to attain before the biotech age. Nevertheless, the genetic manipulation of plants and animals has sparked controversies in different parts of the globe and it continues to be a challenge that the Agbio industry continues to wrestle with. A controversy relevant to Africa is that there are fears that Agbio might create a dependency where third world farmers are dependent on western biotech firms for genetically engineered seedlings.
Medical biotechnology mostly involves the harnessing of Recombinant DNA technology in order to develop solutions in the fields of medicine and healthcare. A heavy user of medical biotechnology is the pharmaceutical industry where a very clear pattern of division of labor exists. Government labs and small biotech firms almost exclusively do all the R & D, while large pharmaceutical firms (Big Pharma) with their financial muscle handle marketing and distribution of biotech products. The biotech industry got started in 1978 when Genentech signed an agreement to produce genetically engineered insulin for large pharmaceutical firm, Eli Lilly.
Industrial biotechnology is the application of biotechnology to the sustainable production of materials, chemicals, and fuels using living cells and enzymes. It has a broad application across many areas including:
- Chemicals
- Food and feed
- Paper and pulp
- Textiles
- Bioenergy
- Materials and Polymers
A notable achievement of industrial biotechnology has been the production of biofuels particularly in Brazil.
I wouldn’t be able to sign off on this article without noting biotech’s effect on the popular imagination through the medium of entertainment. By far most influential of course, in this area is the series of Jurassic Park films of which there are seven in total. Originally inspired by the novels of scientific thriller writing genius, Michael Crichton, the movies have become a staple of global popular culture. Their plots center on dinosaurs that have been brought back into existence using genetic engineering techniques.
In an amazing case of life imitating art, there is a real life project to bring the woolly mammoth back from extinction. The plan is to genetically engineer Asian elephants who happen to be the closest living relative of the wooly mammoth, to have mammoth characteristics and place them in the Artic in a bid to restore that region’s ecosystem and combat climate change. The project is aiming for the first mammoths to appear in 2028.
I have marked the year down.
Bibliography
- Smith, John E. 1996 Biotechnology Third Edition Cambridge: Cambridge University Press
- Oliver Richard W. 2000 The Coming Biotech Age: The Business of Bio-Materials New York: McGraw-Hill





